From the academy
Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents

https://doi.org/10.1016/j.jaad.2014.03.030Get rights and content

Atopic dermatitis is a chronic, pruritic inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in atopic dermatitis management and care, providing recommendations based on the available evidence. In this third of 4 sections, treatment of atopic dermatitis with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option.

Key words

atopic dermatitis
azathioprine
cyclosporin A
interferon gamma
methotrexate
mycophenolate mofetil
oral antihistamines
oral antimicrobials
oral steroids
photochemotherapy
phototherapy
systemic therapy

Abbreviations used

AAD
American Academy of Dermatology
AD
atopic dermatitis
AZA
azathioprine
BB
broadband
CSA
cyclosporin A
FDA
Food and Drug Administration
GI
gastrointestinal
HSV
herpes simplex virus
IFN-G
interferon gamma
MMF
mycophenolate mofetil
MTX
methotrexate
NB
narrowband
PUVA
psoralen plus ultraviolet A
QOL
quality of life
SASSAD
Six Sign Six Area Atopic Dermatitis
SCORAD
SCORing Atopic Dermatitis
TPMT
thiopurine methyltransferase
UV
ultraviolet

Cited by (0)

Funding sources: None.

The authors' conflicts of interest/disclosure statements appear at the end of the article.

View Abstract